Document is current
Any future updates will be listed below
-
Authors
Yang, Dae-Myoung https://orcid.org/0000-0002-1229-7759
Alfano, Ryan
Bauman, Glenn
Thiessen, Jonathan D.
Chin, Joseph
Pautler, Stephen
Moussa, Madeleine
Gomez, Jose A.
Rachinsky, Irina
Gaed, Mena
Chung, Kevin J.
Ward, Aaron
Lee, Ting-Yim https://orcid.org/0000-0001-7605-9752
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04009174 at ClinicalTrials.govDocuments that mention this clinical trial
Short-duration dynamic [18F]DCFPyL PET and CT perfusion imaging to localize dominant intraprostatic lesions in prostate cancer: validation against digital histopathology and comparison to [18F]DCFPyL PET/MR at 120 minutes
https://doi.org/10.1186/s13550-021-00844-0
-
Funding
Funding for this research was provided by:
canada foundation of innovation (Leading-Edge Fund)
ontario institute for cancer research
canadian institutes of health research
- License Information
-
More Information
Article History
Received: 22 June 2021
Accepted: 27 September 2021
First Online: 15 October 2021
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee (University of Western Ontario Research Ethics Boards) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: All research participants consent to publication of data acquired in the approved study.
: Informed consent was obtained from all individual participants included in the study.
: The CT perfusion software is licensed to GE Healthcare (Ting-Yim Lee). All other authors have no competing interests to report.
